Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2000
06/08/2000WO2000032618A1 Nucleic acids and polypeptides of d. melanogaster insulin-like genes and uses thereof
06/08/2000WO2000032239A1 Hapten-carrier conjugates for treating and preventing nicotine addiction
06/08/2000WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000WO2000032220A1 Anti-dandruff composition comprising an antifungal polypeptide
06/08/2000WO2000032218A1 Controlled release formulation comprising gnrh-ii
06/08/2000WO2000032215A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
06/08/2000WO2000032208A2 Isolated material having an anti-organotrophic effect
06/08/2000WO2000032175A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
06/08/2000WO2000032152A2 Compositions and methods for regulating bacterial pathogenesis
06/08/2000WO2000032047A1 Plasmid maintenance system for antigen delivery
06/08/2000WO2000032039A1 PURIFIED AND ISOLATED piwi FAMILY GENES AND GENE PRODUCTS AND METHODS EMPLOYING SAME
06/08/2000WO2000018923A3 Slgp protein and nucleic acid molecule and uses therefor
06/08/2000WO2000015817A3 Stomatin-like genes and their use in plants
06/08/2000WO2000015758A9 Plant resistance to insect pests mediated by viral proteins
06/08/2000WO2000015659A3 Stomach polypeptide zsig28
06/08/2000WO2000015245A3 Stable liquid formulations of botulinum toxin
06/08/2000WO2000014200A3 Essential bacterial genes and their use
06/08/2000WO2000014117A9 Peptide ligands for affinity purification of human factor viii
06/08/2000WO2000012704A9 Enhanced functional expression of g protein-coupled receptors
06/08/2000WO2000012541A3 Cytotoxic peptides modified by bulky or lipophilic moieties
06/08/2000WO2000012536A3 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
06/08/2000WO2000012535A3 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
06/08/2000WO2000011191A3 Tpl-2/cot kinase and methods of use
06/08/2000WO2000011183A3 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000009676A3 Methods of forming neurons
06/08/2000WO2000008142A3 Fibrous proteins and the production thereof
06/08/2000WO2000003012A3 Expression of eukaryotic peptides in plant plastids
06/08/2000WO1999064572A3 Poly(adp-ribose) polymerase gene
06/08/2000WO1999043803A9 Genomic gene encoding hm1.24 antigen protein and promoter thereof
06/08/2000WO1999024076A9 Salicylate derivatized therapeutic and diagnostic agents
06/08/2000DE19958198A1 Mit dem IGF-1 Rezeptor wechselwirkende Proteine (IIPs) With the IGF-1 receptor interacting proteins (IIPs)
06/08/2000DE19856463A1 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors
06/08/2000DE19856052A1 Konjugat zur Anreicherung in neuronalen Zellen Conjugate to accumulate in neuronal cells
06/08/2000CA2503475A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2353798A1 Controlled release formulation comprising gnrh-ii
06/08/2000CA2353590A1 Isolated material having an anti-organotrophic effect
06/08/2000CA2353563A1 Development of novel anti-microbial agents based on bacteriophage genomics
06/08/2000CA2353530A1 Antiviral peptides
06/08/2000CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000CA2353304A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2353102A1 Novel tumor antigen protein art-1 and tumor antigen peptide thereof
06/08/2000CA2353087A1 Isolation and characterization of a n. crassa silencing gene and uses thereof
06/08/2000CA2353080A1 Control of flowering
06/08/2000CA2352760A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2352749A1 Anti-dandruff composition comprising an antifungal polypeptide
06/08/2000CA2352738A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
06/08/2000CA2352539A1 Recombinant soluble fc receptors
06/08/2000CA2352538A1 Erythropoietic compounds
06/08/2000CA2352532A1 Compositions and methods for increasing bone mineralization
06/08/2000CA2352468A1 Ethylene-response-factor1 (erf1) in plants
06/08/2000CA2352466A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000CA2352457A1 Plasmid maintenance system for antigen delivery
06/08/2000CA2351870A1 Scorpion toxins
06/08/2000CA2351731A1 Compositions and methods for regulating bacterial pathogenesis
06/08/2000CA2350597A1 Methods and compositions for restoring conformational stability of a protein of the p53 family
06/08/2000CA2348823A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2000EP1006364A1 Immunoassay for detection of mutant P53 polypeptide in biological fluids
06/07/2000EP1006196A2 Retroviral hybrid vectors pseudotyped with LCMV glycoprotein
06/07/2000EP1006195A1 INFECTIOUS VECTORS AND CLONES OF PLANTS DERIVED FROM THE TURNIP MOSAIC VIRUS (TuMV)
06/07/2000EP1006194A2 C-erbB-2 external domain: GP75
06/07/2000EP1006188A1 Human chemokines beta10 and beta4 polypeptides and nucleic acids
06/07/2000EP1006187A2 Compositions for the diagnosis, prevention, and treatment of tumor progression
06/07/2000EP1006186A1 Human genes
06/07/2000EP1006185A1 Tissue-specific splice variant of recombination-repair gene rad51b associated with t(12;14)-uterine leiomyomas
06/07/2000EP1006184A1 IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof
06/07/2000EP1006183A1 Recombinant soluble Fc receptors
06/07/2000EP1006182A2 Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs
06/07/2000EP1006126A2 Osteogenic peptides
06/07/2000EP1006125A1 Goat epididymal forward motility protein
06/07/2000EP1006124A1 Immunomodulatory and antimicrobial materials, their preparation and use
06/07/2000EP1006123A2 Envelope proteins, methods and uses
06/07/2000EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions
06/07/2000EP1005650A1 Bis-biotin compounds for specific binding assays
06/07/2000EP1005574A2 Method for producing nucleic acid polymers
06/07/2000EP1005553A1 Secretion of carrier-bonded proteins into the periplasma and the extracellular space
06/07/2000EP1005552A1 Member of the hematopoietin receptor superfamily
06/07/2000EP1005551A2 Tissue factor pathway inhibitor-3
06/07/2000EP1005549A2 Prostate tumor polynucleotide and antigen compositions
06/07/2000EP1005548A1 Human galectin-9-like proteins and cdnas encoding these proteins
06/07/2000EP1005547A1 Receptor for a bacillus thuringiensis toxin
06/07/2000EP1005546A2 Compounds for immunotherapy of prostate cancer and methods for their use
06/07/2000EP1005545A1 Human extracellular matrix-1
06/07/2000EP1005544A1 70 human secreted proteins
06/07/2000EP1005543A2 Human herpesvirus - 7 diagnostic and immunologic reagents and uses thereof
06/07/2000EP1005542A1 Apolipoprotein e transgenic animals and assay methods
06/07/2000EP1005537A1 Nucleic acid molecules specific for bacterial antigens and uses thereof
06/07/2000EP1005532A1 Isolated nucleic acid molecules encoding ssx family members and uses thereof
06/07/2000EP1005528A1 Regulated gene expression in yeast
06/07/2000EP1005526A1 Direct expression of peptides into culture media
06/07/2000EP1005494A1 High avidity polyvalent and polyspecific reagents
06/07/2000EP1005492A1 Purification of von willebrand factor by cation exchanger chromatography
06/07/2000EP1005491A1 Modified cytokine receptor protein
06/07/2000EP1005490A1 Zinc free insulin crystals for use in pulmonary compositions
06/07/2000EP1005489A1 Novel polypeptides within the growth factor superfamily
06/07/2000EP1005488A1 Receptor that binds trail
1 ... 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 ... 2916